CervoMed (CRVO) Gross Profit (2011 - 2013)
CervoMed (CRVO) posted Gross Profit of $71667.0 for Q2 2013, down 49.7% sequentially from $142484.0 in Q3 2012, and down 49.7% YoY from $142484.0 in Q2 2012.
CervoMed (CRVO) Gross Profit (2011 - 2013) Analysis & Trends
CervoMed has reported Gross Profit for 3 years, with the latest figure at $71667.0 in Q2 2013.
- Quarterly Gross Profit fell 49.7% year-over-year to $71667.0 in Q2 2013, while the trailing twelve-month figure through Mar 2014 was $71667.0 (down 74.85% YoY) and the FY2013 annual result came in at $71667.0, down 48.34% from the prior year.
- Gross Profit retreated to $71667.0 in Q2 2013 per CRVO's latest filing, from $142484.0 in the prior quarter.
- Over five years, Gross Profit peaked at $142484.0 in Q2 2012 and troughed at -$1.7 million in Q4 2011.
- A 3-year average of -$241743.2 and a median of $34029.0 in 2011 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2012 and 2013: Gross Profit jumped 4048.02% in 2012, then slumped 49.7% in 2013.
- Over 3 years, Gross Profit stood at -$1.7 million in 2011, then jumped by 108.21% to $142484.0 in 2012, then plunged by 49.7% to $71667.0 in 2013.
- According to Business Quant data, Gross Profit over the past three periods registered $71667.0, $142484.0, and $142484.0 for Q2 2013, Q3 2012, and Q2 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 71,667.00 |
| Jun 30, 2013 | 71,667.00 |
| Sep 30, 2012 | 142,484.00 |
| Sep 30, 2012 | 142,484.00 |
| Jun 30, 2012 | 142,484.00 |
| Jun 30, 2012 | 142,484.00 |
| Mar 31, 2012 | -68,960.00 |
| Mar 31, 2012 | -68,960.00 |
| Dec 31, 2011 | -1.73 Mn |
| Dec 31, 2011 | -1.73 Mn |
| Sep 30, 2011 | -3,609.00 |
| Sep 30, 2011 | -3,609.00 |